: Overall Financial Performance Unit: million baht Jan-Jun 2018 % Jan-Jun 2019 % Change % YoY Revenue 254.34 100.0% 273.96 100.0% 19.62 7.7% Cost 144.42 56.8% 147.42 53.8% 3.00 2.1% Gross Profit 109.92 43.2
”. Revenue Business categories For the 3-month period ended 30/9/18 % Change Inc. (Dec) For the 9-month period ended 30/9/18 % Change Inc. (Dec) 2018 2017 2018 2017 THB mm % THB mm % THB mm % THB mm % Sales 1
Change DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 As of March 31, 2020
performance of the Company three-month for the Quarter 1/2020 ended 31 March 2020 are as follows: change Q1/2020 Q1/2019 increase (decrease) Sales 224.5 213.9 5.0% Other income 1.9 10.8 -82.3% Cost of sales
Liabilities and Shareholder's Equity 1,743.53 100.00% 1,574.61 100.00% 168.92 10.73% 30 September 2020 31 December 2019 Change
Table 1: Overall Financial Performance Unit: million baht Jan-Sep 2018 % Jan-Sep 2019 % Change % YoY Revenue 380.50 100.0% 440.78 100.0% 60.28 15.8% Cost 217.33 57.1% 238.03 54.0% 20.70 9.5% Gross Profit
million baht or 4.45 percent. Analysis of the consolidated financial performance Statement of Comprehensive Income (Unit : Million Baht) For the quarter ended 31 March Change 2020 2019 Amount Percent
Deficit from business combination under common control (22.9) (22.9) - - Total equity 11,386.6 10,793.0 593.6 5.5 Statement of Financial Position Change Analysis of Financial Position 10 Assets Total assets